Clinical Trial Update: Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of selinexor in advanced thymic epithelial tumor after chemotherapy was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Epithelial Tumor
• Thymoma

Drugs mentioned

• Selinexor (selinexor)

Snippet

Sponsor: Georgetown University | Conditions: Thymoma, Advanced Thymic Epithelial Tumor | Phase 2 | Status: TERMINATED | Results posted: 2023-02-16